Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Chagas test evaluation and benznidazole treatment study in Bahia
RBR-5zfkxdyNot yet recruiting
- Sponsor
- Fiocruz Bahia
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of benznidazole in American trypanosomiasis (CD) (3 cohorts), sponsored by Fiocruz Bahia. Primary endpoints: Prevalence of Chagas disease, Diagnostic performance of the Bio-Manguinhos rapid Chagas test and 2 more. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
benznidazole
03
Conditions
American trypanosomiasis (CD)
Beyond the preview
Go deeper on RBR-5zfkxdy.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5zfkxdy.